Advancing excellence in laboratory medicine for better healthcare worldwide

Key Publications on Diagnostic and Serology Testing:

Disclaimer: This collection of resources on this webpage reflects a rapidly changing situation and due to the need for quick answers during the COVID-19 pandemic, we acknowledge that most fast-tracked publications are based on observations, often on a small number of cases, which would be considered as preliminary evidence. The IFCC Task Force has not critically appraised all resources cited here for scientific validity but tried to present information that is believed to help laboratory professionals in formulating their local policies in a more informed manner. The interim advice or conclusions presented here may change as more information is gathered.



Click on the title to visit the relevant section: Opinion - Molecular Testing - Antigen TestingSerology Testing



  1. Arturo EC, Saphire EO. Lifted Up from Lockdown. Cell. 2020 Oct 1;183(1):1-3. doi: 10.1016/j.cell.2020.09.027. PMID: 33007260; PMCID: PMC7528821.
  2. Lippi G, Henry BM, Sanchis-Gomar F. Potential drawbacks of frequent asymptomatic coronavirus disease 2019 (COVID-19) testing. Infect Control Hosp Epidemiol. 2020 Oct 29:1-2. doi: 10.1017/ice.2020.1305. Epub ahead of print. PMID: 33115549.
  3. Gill M, Gray M. Mass testing for covid-19 in the UK. BMJ. 2020 Nov 16;371:m4436. doi: 10.1136/bmj.m4436. PMID: 33199289.
  4. Shaman J, Galanti M. Will SARS-CoV-2 become endemic? Science. 2020 Oct 14:eabe5960. doi: 10.1126/science.abe5960. Epub ahead of print. PMID: 33055131.
  5. Dying in a Leadership Vacuum. N Engl J Med. 2020 Oct 8;383(15):1479-1480. doi: 10.1056/NEJMe2029812. PMID: 33027574.
  6. Mina MJ, Parker R, Larremore DB. Rethinking Covid-19 Test Sensitivity - A Strategy for Containment. N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2025631. Epub ahead of print. PMID: 32997903.


Molecular Testing:

  1. Manning BJ, Khan WA, Peña JM, Fiore ES, Boisvert H, Tudino MC, Barney RE, Wilson MK, Singh S, Mowatt JA, Thompson HJ, Tsongalis GJ, Blake WJ. High-Throughput CRISPR-Cas13 SARS-CoV-2 Test. Clin Chem. 2021 Oct 26:hvab238. doi: 10.1093/clinchem/hvab238. Epub ahead of print. PMID: 34718481.
  2. Berenger BM, Stokes W, Turnbull L, Pabbaraju K, Zelyas N, Venner AA, Tipples GA. Save the COVID-19 point of care nucleic acid test swab after testing to identify variants of concern. Clin Chem. 2021 Oct 23:hvab243. doi: 10.1093/clinchem/hvab243. Epub ahead of print. PMID: 34687302; PMCID: PMC8574308.
  3. Evans D, Cowen S, Kammel M, O'Sullivan DM, Stewart G, Grunert HP, Moran-Gilad J, Verwilt J, In J, Vandesompele J, Harris K, Hong KH, Storey N, Hingley-Wilson S, Dühring U, Bae YK, Foy C, Braybrook J, Zeichhardt H, Huggett JF. The dangers of using Cq to quantify nucleic acid in biological samples; a lesson from COVID-19. Clin Chem. 2021 Oct 11:hvab219. doi: 10.1093/clinchem/hvab219. Epub ahead of print. PMID: 34633030.
  4. Poon LLM. A Push for Real Normal: Mass Screening for COVID-19. Clin Chem. 2021 Oct 7:hvab190. doi: 10.1093/clinchem/hvab190. Epub ahead of print. PMID: 34617102; PMCID: PMC8500115.
  5. Buchta C, Camp JV, Jovanovic J, Radler U, Puchhammer-Stöckl E, Benka B, Huf W, Müller MM, Griesmacher A, Aberle SW, Görzer I. A look at the precision, sensitivity and specificity of SARS-CoV-2 RT-PCR assays through a dedicated external quality assessment round. Clin Chem Lab Med. 2021 Oct 20. doi: 10.1515/cclm-2021-1004. Epub ahead of print. PMID: 34668361.
  6. Berg MG, Zhen W, Lucic D, Degli-Angeli EJ, Anderson M, Forberg K, Olivo A, Sheikh F, Toolsie D, Greninger AL, Cloherty GA, Coombs RW, Berry GJ. Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity. J Clin Virol. 2021 Oct;143:104945. doi: 10.1016/j.jcv.2021.104945. Epub 2021 Aug 17. PMID: 34450558; PMCID: PMC8367731.
  7. Caza M, Hogan CA, Jassem A, Prystajecky N, Hadzic A, Wilmer A. Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI). J Clin Virol. 2021 Nov;144:104996. doi: 10.1016/j.jcv.2021.104996. Epub 2021 Oct 2. PMID: 34628158; PMCID: PMC8487322.
  8. Wack M, Péré H, Demory-Guinet N, Kassis-Chikhani N, Janot L, Vedie B, Izquierdo L, Bélec L, Veyer D. No SARS-CoV-2 reinfection among staff health-care workers: Prospective hospital-wide screening during the first and second waves in Paris. J Clin Virol. 2021 Oct 19;145:104999. doi: 10.1016/j.jcv.2021.104999. Epub ahead of print. PMID: 34695725; PMCID: PMC8525071.

Less recent publications on Molecular Testing:

  1. Chen H, Li Z, Feng S, et al. Femtomolar SARS-CoV-2 Antigen Detection Using the Microbubbling Digital Assay with Smartphone Readout Enables Antigen Burden Quantitation and Tracking [published online ahead of print, 2021 Aug 12]. Clin Chem. 2021;hvab158. doi:10.1093/clinchem/hvab158
  2. Stokes W, Kanji J, Hu J, Zelyas N, Berenger BM. Wide Variation in Cycle Threshold Values Cloud the Interpretation of COVID-19 Infectiousness [published online ahead of print, 2021 Jul 29]. Clin Chem. 2021;hvab145. doi:10.1093/clinchem/hvab145
  3. Srivatsan S, Heidl S, Pfau B, et al. SwabExpress: An end-to-end protocol for extraction-free COVID-19 testing. Preprint. bioRxiv. 2021;2020.04.22.056283. Published 2021 Apr 29. doi:10.1101/2020.04.22.056283
  4. Karon BS, Donato L, Bridgeman AR, et al. Analytical sensitivity and specificity of four point of care rapid antigen diagnostic tests for SARS-CoV-2 using real-time quantitative PCR, quantitative droplet digital PCR, and a mass spectrometric antigen assay as comparator methods [published online ahead of print, 2021 Jul 8]. Clin Chem. 2021;hvab138. doi:10.1093/clinchem/hvab138
  5. Potter RF, Ransom EM, Wallace MA, et al. Multiplatform assessment of saliva for SARS-CoV-2 molecular detection in symptomatic healthcare personnel and patients presenting to the emergency department [published online ahead of print, 2021 Sep 7]. J Appl Lab Med. 2021;jfab115. doi:10.1093/jalm/jfab115
  6. Hardy NL, Luethy PM. Evaluation of Inappropriate COVID-19 RT-PCR Test Utilization at an academic medical center [published online ahead of print, 2021 Jun 30]. J Appl Lab Med. 2021;jfab081. doi:10.1093/jalm/jfab081
  7. Lee SS, Park JH, Bae YK. Comparison of two digital PCR methods for EGFR DNA and SARS-CoV-2 RNA quantification. Clin Chim Acta. 2021;521:9-18. doi:10.1016/j.cca.2021.06.016
  8. Stelzl E, Kessler HH, Mustafa HG, et al. Alternative detection of SARS-CoV-2 RNA by a new assay based on mass spectrometry [published online ahead of print, 2021 Aug 12]. Clin Chem Lab Med. 2021;10.1515/cclm-2021-0483. doi:10.1515/cclm-2021-0483
  9. Buchta C, Camp JV, Jovanovic J, et al. The versatility of external quality assessment for the surveillance of laboratory and in vitrodiagnostic performance: SARS-CoV-2 viral genome detection in Austria. Clin Chem Lab Med. 2021;59(10):1735-1744. Published 2021 Jun 30. doi:10.1515/cclm-2021-0604
  10. Martin A, Storto A, Le Hingrat Q, et al. High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings. J Clin Virol. 2021;141:104895. doi:10.1016/j.jcv.2021.104895
  11. Ong DSY, Koeleman JGM, Vaessen N, Breijer S, Paltansing S, de Man P. Rapid screening method for the detection of SARS-CoV-2 variants of concern. J Clin Virol. 2021;141:104903. doi:10.1016/j.jcv.2021.104903
  12. Nörz D, Grunwald M, Olearo F, et al. Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7. J Clin Virol. 2021;141:104894. doi:10.1016/j.jcv.2021.104894
  13. Burnes LE, Clark ST, Sheldrake E, et al. One swab, two tests: Validation of dual SARS-CoV-2 testing on the Abbott ID NOW™. J Clin Virol. 2021;141:104896. doi:10.1016/j.jcv.2021.104896
  14. Singh AK, Stellrecht KA, Arunachalam T, et al. Lack of active SARS-CoV-2 virus in a subset of PCR-positive COVID-19 congregate care patients. J Clin Virol. 2021;141:104879. doi:10.1016/j.jcv.2021.104879
  15. Camp JV, Buchta C, Jovanovic J, et al. RT-PCR based SARS-CoV-2 variant screening assays require careful quality control. J Clin Virol. 2021;141:104905. doi:10.1016/j.jcv.2021.104905
  16. Lind A, Barlinn R, Landaas ET, et al. Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory. J Clin Virol. 2021;141:104906. doi:10.1016/j.jcv.2021.104906
  17. Berg MG, Zhen W, Lucic D, et al. Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity. J Clin Virol. 2021;143:104945. doi:10.1016/j.jcv.2021.104945
  18. Paradis S, Lockamy E, Cooper CK, Young S. Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system. J Clin Virol. 2021;143:104946. doi:10.1016/j.jcv.2021.104946
  19. Andreani J, Lupo J, Germi R, et al. Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?. J Clin Virol. 2021;143:104947. doi:10.1016/j.jcv.2021.104947
  20. Bongiovanni M, Liuzzi G, Schiavon L, Gianturco L, Giuliani G. Evaluation of the immune response to COVID-19 vaccine mRNA BNT162b2 and correlation with previous COVID-19 infection. J Clin Virol. 2021;143:104962. doi:10.1016/j.jcv.2021.104962
  21. Migueres M, Lhomme S, Trémeaux P, et al. Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants. J Clin Virol. 2021;143:104969. doi:10.1016/j.jcv.2021.104969
  22. Fernandes PADC, Ferreira FADC, Morais OM, et al. Performance of saliva as a specimen to detect SARS-CoV-2. J Clin Virol. 2021;142:104913. doi:10.1016/j.jcv.2021.104913
  23. Uchida S, Uwamino Y, Uno S, et al. Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan. J Clin Virol. 2021;142:104915. doi:10.1016/j.jcv.2021.104915


Antigen Testing:

  1. Puyskens A, Krause E, Michel J, Nübling CM, Scheiblauer H, Bourquain D, Grossegesse M, Valusenko R, Corman VM, Drosten C, Zwirglmaier K, Wölfel R, Lange C, Kramer J, Friesen J, Ignatius R, Müller M, Schmidt-Chanasit J, Emmerich P, Schaade L, Nitsche A. Establishment of a specimen panel for the decentralised technical evaluation of the sensitivity of 31 rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill. 2021 Nov;26(44). doi: 10.2807/1560-7917.ES.2021.26.44.2100442. PMID: 34738516.
  2. Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, Zwirglmaier K, Lange C, Emmerich P, Müller M, Knauer O, Nübling CM. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill. 2021 Nov;26(44). doi: 10.2807/1560-7917.ES.2021.26.44.2100441. PMID: 34738515.
  3. Domínguez Fernández M, Peña Rodríguez MF, Lamelo Alfonsín F, Bou Arévalo G. Experience with Panbio™ rapid antigens test device for the detection of SARS-CoV-2 in nursing homes. Enferm Infecc Microbiol Clin (Engl Ed). 2021 Oct 25:S2529-993X(21)00211-2. doi: 10.1016/j.eimce.2021.10.002. Epub ahead of print. PMID: 34732341; PMCID: PMC8542453.
  4. Turcato G, Zaboli A, Pfeifer N, Sibilio S, Tezza G, Bonora A, Ciccariello L, Ausserhofer D. Rapid antigen test to identify COVID-19 infected patients with and without symptoms admitted to the Emergency Department. Am J Emerg Med. 2021 Oct 22;51:92-97. doi: 10.1016/j.ajem.2021.10.022. Epub ahead of print. PMID: 34717211; PMCID: PMC8530784

Less recent publications on Antigen Testing

  1. Brasen CL, Christensen H, Olsen DA, et al. Daily monitoring of viral load measured as SARS-CoV-2 antigen and RNA in blood, IL-6, CRP and complement C3d predicts outcome in patients hospitalized with COVID-19 [published online ahead of print, 2021 Aug 27]. Clin Chem Lab Med. 2021;10.1515/cclm-2021-0694. doi:10.1515/cclm-2021-0694
  2. Hartard C, Berger S, Josse T, Schvoerer E, Jeulin H. Performance evaluation of an automated SARS-CoV-2 Ag test for the diagnosis of COVID-19 infection on nasopharyngeal swabs [published online ahead of print, 2021 Jul 30]. Clin Chem Lab Med. 2021;10.1515/cclm-2021-0569. doi:10.1515/cclm-2021-0569
  3. Bourassa L, Perchetti GA, Phung Q, et al. A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance. J Clin Virol. 2021;141:104900. doi:10.1016/j.jcv.2021.104900
  4. Van der Moeren N, Zwart VF, Goderski G, et al. Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL. J Clin Virol. 2021;141:104909. doi:10.1016/j.jcv.2021.104909
  5. Lee J, Song JU, Shim SR. Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis [published online ahead of print, 2021 Sep 16]. J Clin Virol. 2021;144:104985. doi:10.1016/j.jcv.2021.104985
  6. Merino-Amador P, González-Donapetry P, Domínguez-Fernández M, et al. Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study. J Clin Virol. 2021;143:104961. doi:10.1016/j.jcv.2021.104961
  7. Gandolfo C dr, Morecchiato F dr, Pistello M prof, Rossolini GM prof, Cusi MG prof. Detection of SARS-CoV-2 N protein allelic variants by rapid high-throughput CLEIA antigen assay. J Clin Virol. 2021;142:104942. doi:10.1016/j.jcv.2021.104942
  8. Ngo Nsoga MT, et alI. Diagnostic accuracy of Panbio rapid antigen tests on oropharyngeal swabs for detection of SARS-CoV-2. PLoS One. 2021 Jun 24;16(6):e0253321. doi: 10.1371/journal.pone.0253321. PMID: 34166410.
  9. Smith RD, et al. Clinical Evaluation of Sofia Rapid Antigen Assay for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 among Emergency Department to Hospital Admissions. Infect Control Hosp Epidemiol. 2021 Jun 24:1-22. doi: 10.1017/ice.2021.281. Epub ahead of print. PMID: 34162449.
  10. Hanson KE, et al. The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing. Clin Infect Dis. 2021 Jun 23:ciab557. doi: 10.1093/cid/ciab557. Epub ahead of print. PMID: 34160592.
  11. Eleftheriou I, et al Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children. J Med Virol. 2021 Jun 22. doi: 10.1002/jmv.27149. Epub ahead of print. PMID: 34156112.
  12. Lindner AK, et al. Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test. J Clin Virol. 2021 May 29;141:104874. doi: 10.1016/j.jcv.2021.104874. Epub ahead of print. PMID: 34144452; PMCID: PMC8163726.
  13. Ferté T, et al. Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study. J Clin Virol. 2021 Jun 5;141:104878. doi: 10.1016/j.jcv.2021.104878. Epub ahead of print. PMID: 34134035; PMCID: PMC8178956.
  14. Blairon L, Cupaiolo R, Thomas I, Piteüs S, Wilmet A, Beukinga I, Tré-Hardy M. Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance. J Med Virol. 2021 May 29. doi: 10.1002/jmv.27108. Epub ahead of print. PMID: 34050945.
  15. Koller G, Morrell AP, Galão RP, Pickering S, MacMahon E, Johnson J, Ignatyev K, Neil SJD, Elsharkawy S, Fleck R, Machado PMP, Addison O. More than the Eye Can See: Shedding New Light on SARS-CoV-2 Lateral Flow Device-Based Immunoassays. ACS Appl Mater Interfaces. 2021 May 28. doi: 10.1021/acsami.1c04283. Epub ahead of print. PMID: 34048220.
  16. Krüger LJ, Gaeddert M, Tobian F, Lainati F, Gottschalk C, Klein JAF, Schnitzler P, Kräusslich HG, Nikolai O, Lindner AK, Mockenhaupt FP, Seybold J, Corman VM, Drosten C, Pollock NR, Knorr B, Welker A, de Vos M, Sacks JA, Denkinger CM; study team. The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2-Evaluation of the accuracy and ease-of-use. PLoS One. 2021 May 27;16(5):e0247918. doi: 10.1371/journal.pone.0247918. PMID: 34043631.
  17. Shaikh N, Friedlander EJ, Tate PJ, Liu H, Chang CH, Wells A, Hoberman A. Performance of a Rapid SARS-CoV-2 Antigen Detection Assay in Symptomatic Children. Pediatrics. 2021 May 26:e2021050832. doi: 10.1542/peds.2021-050832. Epub ahead of print. PMID: 34039718.
  18. Taher J, Randell EW, Arnoldo S, Bailey D, De Guire V, Kaur S, Knauer M, Petryayeva E, Poutanen SM, Shaw JLV, Uddayasankar U, White-Al Habeeb N, Konforte D. Canadian society of clinical chemists (CSCC) consensus guidance for testing, selection and quality management of SARS-CoV-2 point-of-care tests. Clin Biochem. 2021 May 25:S0009-9120(21)00151-X. doi: 10.1016/j.clinbiochem.2021.05.010. Epub ahead of print. PMID: 34048776.
  19. Klein JAF, Krüger LJ, Tobian F, Gaeddert M, Lainati F, Schnitzler P, Lindner AK, Nikolai O, Knorr B, Welker A, de Vos M, Sacks JA, Escadafal C, Denkinger CM; Study Team. Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test. Med Microbiol Immunol. 2021 May 24:1–6. doi: 10.1007/s00430-021-00710-9. Epub ahead of print. PMID: 34028625; PMCID: PMC8142294.
  20. Koeleman JGM, Brand H, de Man SJ, Ong DSY. Clinical evaluation of rapid point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021 May 22:1–7. doi: 10.1007/s10096-021-04274-7. Epub ahead of print. PMID: 34021840; PMCID: PMC8140309.
  21. Ulhaq ZS, Soraya GV. The diagnostic accuracy of seven commercial molecular in vitro SARS-CoV-2 detection tests: a rapid meta-analysis. Expert Rev Mol Diagn. 2021 May 20. doi: 10.1080/14737159.2021.1933449. Epub ahead of print. PMID: 34015984.
  22. Reza S, Corentin D, Te-Din H, Pierre B, Stéphanie E, Isaline W, Boutaina H, Pauline R, Olivier D. Rapid COVID-19 antigenic tests: Usefulness of a modified method for diagnosis. J Med Virol. 2021 May 19. doi: 10.1002/jmv.27094. Epub ahead of print. PMID: 34009649.
  23. Hayer J, Kasapic D, Zemmrich C. Real-world clinical performance of commercial SARS-CoV-2 rapid antigen tests in suspected COVID-19: A systematic meta-analysis of available data as per November 20, 2020. Int J Infect Dis. 2021 May 17:S1201-9712(21)00431-8. doi: 10.1016/j.ijid.2021.05.029. Epub ahead of print. PMID: 34015523; PMCID: PMC8127520.
  24. Pérez-García F, Romanyk J, Gutiérrez HM, Ballestero AL, Ranz IP, Arroyo JG, Ventosa VG, Pérez-Tanoira R, Cruz CD, Cuadros-González J. Comparative evaluation of Panbio and SD Biosensor antigen rapid diagnostic tests for COVID-19 diagnosis. J Med Virol. 2021 May 17. doi: 10.1002/jmv.27089. Epub ahead of print. PMID: 34002864.
  25. Brihn A, Chang J, OYong K, Balter S, Terashita D, Rubin Z, Yeganeh N. Diagnostic Performance of an Antigen Test with RT-PCR for the Detection of SARS-CoV-2 in a Hospital Setting - Los Angeles County, California, June-August 2020. MMWR Morb Mortal Wkly Rep. 2021 May 14;70(19):702-706. doi: 10.15585/mmwr.mm7019a3. PMID: 33983916; PMCID: PMC8118154.
  26. Abbasi J. A Next-Generation Rapid, Accurate SARS-CoV-2 Antibody Test. JAMA. 2021 May 11;325(18):1825. doi: 10.1001/jama.2021.6333. PMID: 33974035.
  27. Lee LYW, Rozmanowski S, Pang M, Charlett A, Anderson C, Hughes GJ, Barnard M, Peto L, Vipond R, Sienkiewicz A, Hopkins S, Bell J, Crook DW, Gent N, Walker AS, Peto TEA, Eyre DW. SARS-CoV-2 infectivity by viral load, S gene variants and demographic factors and the utility of lateral flow devices to prevent transmission. Clin Infect Dis. 2021 May 11:ciab421. doi: 10.1093/cid/ciab421. Epub ahead of print. PMID: 33972994; PMCID: PMC8136027.
  28. Bornemann L, Kaup O, Kleideiter J, Panning M, Ruprecht B, Wehmeier M. Real-life evaluation of the Sofia SARS-CoV-2 antigen assay in a large tertiary care hospital. J Clin Virol. 2021 May 10;140:104854. doi: 10.1016/j.jcv.2021.104854. Epub ahead of print. PMID: 34044330; PMCID: PMC8108474.
  29. Holzner C, Pabst D, Anastasiou OE, Dittmer U, Manegold RK, Risse J, Fistera D, Kill C, Falk M. SARS-CoV-2 rapid antigen test: Fast-safe or dangerous? An analysis in the emergency department of an university hospital. J Med Virol. 2021 May 9. doi: 10.1002/jmv.27033. Epub ahead of print. PMID: 33969499.
  30. Fouzas S. SARS-CoV-2 rapid antigen detection tests. Lancet Infect Dis. 2021 May 4:S1473-3099(21)00206-1. doi: 10.1016/S1473-3099(21)00206-1. Epub ahead of print. PMID: 33961800; PMCID: PMC8096322.
  31. Thakur P, Saxena S, Manchanda V, Rana N, Goel R, Arora R. Utility of Antigen-Based Rapid Diagnostic Test for Detection of SARS-CoV-2 Virus in Routine Hospital Settings. Lab Med. 2021 Apr 30:lmab033. doi: 10.1093/labmed/lmab033. Epub ahead of print. PMID: 33928384.
  32. Bruzzone B, De Pace V, Caligiuri P, Ricucci V, Guarona G, Pennati BM, Boccotti S, Orsi A, Domnich A, Da Rin G, Icardi G. Comparative diagnostic performance of different rapid antigen detection tests for COVID-19 in the real-world hospital setting. Int J Infect Dis. 2021 Apr 27:S1201-9712(21)00384-2. doi: 10.1016/j.ijid.2021.04.072. Epub ahead of print. PMID: 33930540; PMCID: PMC8078031.
  33. Bohn MK, Lippi G, Horvath AR, Erasmus R, Grimmler M, Gramegna M, Mancini N, Mueller R, Rawlinson WD, Menezes ME, Patru MM, Rota F, Sethi S, Singh K, Yuen KY, Wang CB, Adeli K; IFCC Taskforce on COVID-19. IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals. Clin Chem Lab Med. 2021 Apr 27. doi: 10.1515/cclm-2021-0455. Epub ahead of print. PMID: 33908222.
  34. Baro B, Rodo P, Ouchi D, Bordoy AE, Saya Amaro EN, Salsench SV, Molinos S, Alemany A, Ubals M, Corbacho-Monné M, Millat-Martinez P, Marks M, Clotet B, Prat N, Ara J, Vall-Mayans M, G-Beiras C, Bassat Q, Blanco I, Mitjà O. Performance characteristics of five antigen-detecting rapid diagnostic test (Ag-RDT) for SARS-CoV-2 asymptomatic infection: a head-to-head benchmark comparison. J Infect. 2021 Apr 18:S0163-4453(21)00191-2. doi: 10.1016/j.jinf.2021.04.009. Epub ahead of print. PMID: 33882299; PMCID: PMC8053403.
  35. Kenyeres B, Ánosi N, Bányai K, Mátyus M, Orosz L, Kiss A, Kele B, Burián K, Lengyel G. Comparison of four PCR and two point of care assays used in the laboratory detection of SARS-CoV-2. J Virol Methods. 2021 Apr 16;293:114165. doi: 10.1016/j.jviromet.2021.114165. Epub ahead of print. PMID: 33872650; PMCID: PMC8051013.
  36. Häuser F, Sprinzl MF, Dreis KJ, Renzaho A, Youhanen S, Kremer WM, Podlech J, Galle PR, Lackner KJ, Rossmann H, Lemmermann NA. Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission. Med Microbiol Immunol. 2021 Apr 15:1–7. doi: 10.1007/s00430-021-00706-5. Epub ahead of print. PMID: 33856557; PMCID: PMC8047582.
  37. Ford L, Lee C, Pray IW, Cole D, Bigouette JP, Abedi GR, Bushman D, Delahoy MJ, Currie DW, Cherney B, Kirby M, Fajardo G, Caudill M, Langolf K, Kahrs J, Zochert T, Kelly P, Pitts C, Lim A, Aulik N, Tamin A, Harcourt JL, Queen K, Zhang J, Whitaker B, Browne H, Medrzycki M, Shewmaker P, Bonenfant G, Zhou B, Folster J, Bankamp B, Bowen MD, Thornburg NJ, Goffard K, Limbago B, Bateman A, Tate JE, Gieryn D, Kirking HL, Westergaard R, Killerby M; CDC COVID-19 Surge Laboratory Group. Epidemiologic characteristics associated with SARS-CoV-2 antigen-based test results, rRT-PCR cycle threshold values, subgenomic RNA, and viral culture results from university testing. Clin Infect Dis. 2021 Apr 13:ciab303. doi: 10.1093/cid/ciab303. Epub ahead of print. PMID: 33846714.
  38. Corman VM, Haage VC, Bleicker T, Schmidt ML, Mühlemann B, Zuchowski M, Jo WK, Tscheak P, Möncke-Buchner E, Müller MA, Krumbholz A, Drexler JF, Drosten C. Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. Lancet Microbe. 2021 Apr 7. doi: 10.1016/S2666-5247(21)00056-2. Epub ahead of print. PMID: 33846704; PMCID: PMC8026170.
  39. Yin N, Debuysschere C, Decroly M, Bouazza FZ, Collot V, Martin C, Ponthieux F, Dahma H, Gilbert M, Wautier M, Duterme C, De Vos N, Delforge ML, Malinverni S, Cotton F, Bartiaux M, Hallin M. SARS-CoV-2 Diagnostic Tests: Algorithm and Field Evaluation From the Near Patient Testing to the Automated Diagnostic Platform. Front Med (Lausanne). 2021 Apr 6;8:650581. doi: 10.3389/fmed.2021.650581. PMID: 33889587; PMCID: PMC8055843.
  40. Jungnick S, Hobmaier B, Mautner L, Hoyos M, Haase M, Baiker A, Lahne H, Eberle U, Wimmer C, Hepner S, Sprenger A, Berger C, Dangel A, Wildner M, Liebl B, Ackermann N, Sing A, Fingerle V; Bavarian SARS-CoV-2-Public Health Laboratory Team; Bavarian SARS-CoV-Public Health Laboratory Team. Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021. Euro Surveill. 2021 Apr;26(16):2100413. doi: 10.2807/1560-7917.ES.2021.26.16.2100413. PMID: 33890568; PMCID: PMC8063588.
  41. Sood N, Shetgiri R, Rodriguez A, Jimenez D, Treminino S, Daflos A, Simon P. Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting. PLoS One. 2021 Apr 5;16(4):e0249710. doi: 10.1371/journal.pone.024971
  42. Selove W, Rao LV. Performance of rapid SOFIA Influenza A+ B test compared to Luminex x-TAG respiratory viral panel assay in the diagnosis of influenza A, B, and subtype H3. Journal of Investigative Medicine. 2016 Apr 1;64(4):905-7. PMID: 26911275
  43. CDC Guidelines for Rapid Antigen Testing for SARS-CoV-2:
  44. Stokes W, Berenger BM, Portnoy D, Scott B, Szelewicki J, Singh T, Venner AA, Turnbull L, Pabbaraju K, Shokoples S, Wong AA, Gill K, Guttridge T, Proctor D, Hu J, Tipples G. Clinical performance of the Abbott Panbio with nasopharyngeal, throat, and saliva swabs among symptomatic individuals with COVID-19. Eur J Clin Microbiol Infect Dis. 2021 Mar 20. doi: 10.1007/s10096-021-04202-9. Epub ahead of print. PMID: 33742322.
  45. Landaas ET, Storm ML, Tollånes MC, Barlinn R, Kran AB, Bragstad K, Christensen A, Andreassen T. Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort. J Clin Virol. 2021 Mar 10:104789. doi: 10.1016/j.jcv.2021.104789. Epub ahead of print. PMID: 33736946; PMCID: PMC7944803.
  46. Trobajo-Sanmartín C, Navascués A, Miqueleiz A, Ezpeleta C. Evaluation of the rapid antigen test CerTest SARS-CoV-2 as an alternative COVID-19 diagnosis technique. Infect Dis (Lond). 2021 Mar 18:1-3. doi: 10.1080/23744235.2021.1902563. Epub ahead of print. PMID: 33734934.
  47. Iglὁi Z, Velzing J, van Beek J, van de Vijver D, Aron G, Ensing R, Benschop K, Han W, Boelsums T, Koopmans M, Geurtsvankessel C, Molenkamp R. Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands. Emerg Infect Dis. 2021 Mar 16;27(5). doi: 10.3201/eid2705.204688. Epub ahead of print. PMID: 33724916.
  48. Jääskeläinen AE, Ahava MJ, Jokela P, Szirovicza L, Pohjala S, Vapalahti O, Lappalainen M, Hepojoki J, Kurkela S. Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection. J Clin Virol. 2021 Mar 5;137:104785. doi: 10.1016/j.jcv.2021.104785. Epub ahead of print. PMID: 33711694; PMCID: PMC7934791.
  49. Olearo F, Nörz D, Heinrich F, Sutter JP, Roedl K, Schultze A, Wiesch JSZ, Braun P, Oestereich L, Kreuels B, Wichmann D, Aepfelbacher M, Pfefferle S, Lütgehetmann M. Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR. J Clin Virol. 2021 Mar 3;137:104782. doi: 10.1016/j.jcv.2021.104782. Epub ahead of print. PMID: 33711691; PMCID: PMC7927591.
  50. Paltiel AD, Zheng A, Sax PE. Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission. Ann Intern Med. 2021 Mar 9. doi: 10.7326/M21-0510. Epub ahead of print. PMID: 33683930.
  51. Strand R, Thelaus L, Fernström N, Sunnerhagen T, Lindroth Y, Linder A, Rasmussen M. Rapid diagnostic testing for SARS-CoV-2: Validation and comparison of three point-of-care antibody tests. J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26913. Epub ahead of print. PMID: 33666238.
  52. Kiang MV, Chin ET, Huynh BQ, Chapman LAC, Rodríguez-Barraquer I, Greenhouse B, Rutherford GW, Bibbins-Domingo K, Havlir D, Basu S, Lo NC. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study. Lancet Infect Dis. 2021 Mar 22:S1473-3099(21)00134-1. doi: 10.1016/S1473-3099(21)00134-1
  53. Thommes L, Burkert FR, Öttl KW, Goldin D, Loacker L, Lanser L, Griesmacher A, Theurl I, Weiss G, Bellmann-Weiler R. Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients. Int J Infect Dis. 2021 Feb 17:S1201-9712(21)00138-7. doi: 10.1016/j.ijid.2021.02.052. Epub ahead of print. PMID: 33609774.
  54. Mina MJ, Peto TE, García-Fiñana M, Semple MG, Buchan IE. Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19. Lancet. 2021 Feb 17:S0140-6736(21)00425-6. doi: 10.1016/S0140-6736(21)00425-6. Epub ahead of print. PMID: 33609444.
  55. Cerutti H, Ricci V, Tesi G, Soldatini C, Castria M, Vaccaro MN, Tornesi S, Toppi S, Verdiani S, Brogi A. Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development. J Clin Lab Anal. 2021 Feb 19:e23735. doi: 10.1002/jcla.23735. Epub ahead of print. PMID: 33608968.
  56. González-Donapetry P, García-Clemente P, Bloise I, García-Sánchez C, Sánchez Castellano MÁ, Romero MP, Gutiérrez Arroyo A, Mingorance J, de Ceano-Vivas La Calle M, García-Rodriguez J; SARS-CoV-2 Working Group. Think of the Children: Evaluation of SARS-CoV-2 Rapid Antigen Test in Pediatric Population. Pediatr Infect Dis J. 2021 Feb 17. doi: 10.1097/INF.0000000000003101. Epub ahead of print. PMID: 33605674.
  57. Eshghifar N, Busheri A, Shrestha R, Beqaj S. Evaluation of Analytical Performance of Seven Rapid Antigen Detection Kits for Detection of SARS-CoV-2 Virus. Int J Gen Med. 2021 Feb 12;14:435-440. doi: 10.2147/IJGM.S297762. PMID: 33603450; PMCID: PMC7886288.
  58. Merino P, Guinea J, Muñoz-Gallego I, González-Donapetry P, Galán JC, Antona N, Cilla G, Hernáez-Crespo S, Díaz-de Tuesta JL, Torrella AG, González-Romo F, Escribano P, Sánchez-Castellano MÁ, Sota-Busselo M, Delgado-Iribarren A, García J, Cantón R, Muñoz P, Folgueira MD, Cuenca-Estrella M, Oteo-Iglesias J; Spanish Panbio™ COVID-19 validation group, Medrano S, Pérez A, Galar A, Martínez-Expósito O, Alejo-Cancho I, Martín-Higuera MC, Rolo M, Estévez MJ, Bravo T, Vicente D, Montes M. Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection. Clin Microbiol Infect. 2021 Feb 15:S1198-743X(21)00076-8. doi: 10.1016/j.cmi.2021.02.001. Epub ahead of print. PMID: 33601009; PMCID: PMC7884234.
  59. Gili A, Paggi R, Russo C, Cenci E, Pietrella D, Graziani A, Stracci F, Mencacci A. Evaluation of automated test Lumipulse® G SARS-CoV-2 antigen assay for detection of SARS-CoV-2 nucleocapsid protein (NP) in nasopharyngeal swabs for community and population screening. Int J Infect Dis. 2021 Feb 26:S1201-9712(21)00184-3. doi: 10.1016/j.ijid.2021.02.098. Epub ahead of print. PMID: 33647511; PMCID: PMC7908845.
  60. Pérez-García F, Romanyk J, Gómez-Herruz P, Arroyo T, Pérez-Tanoira R, Linares M, Pérez Ranz I, Labrador Ballestero A, Moya Gutiérrez H, Ruiz-Álvarez MJ, Cuadros-González J. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection. J Clin Virol. 2021 Feb 21;137:104781. doi: 10.1016/j.jcv.2021.104781. Epub ahead of print. PMID: 33639492; PMCID: PMC7897407.
  61. Drain PK, Ampajwala M, Chappel C, Gvozden AB, Hoppers M, Wang M, Rosen R, Young S, Zissman E, Montano M. A Rapid, High-Sensitivity SARS-CoV-2 Nucleocapsid Immunoassay to Aid Diagnosis of Acute COVID-19 at the Point of Care: A Clinical Performance Study. Infect Dis Ther. 2021 Feb 24:1–9. doi: 10.1007/s40121-021-00413-x. Epub ahead of print. PMID: 33629225; PMCID: PMC7904038.
  62. Pollock NR, Jacobs JR, Tran K, Cranston AE, Smith S, O'Kane CY, Roady TJ, Moran A, Scarry A, Carroll M, Volinsky L, Perez G, Patel P, Gabriel S, Lennon NJ, Madoff LC, Brown C, Smole SC. Performance and Implementation Evaluation of the Abbott BinaxNOW Rapid Antigen Test in a High-throughput Drive-through Community Testing Site in Massachusetts. J Clin Microbiol. 2021 Feb 23:JCM.00083-21. doi: 10.1128/JCM.00083-21. Epub ahead of print. PMID: 33622768.
  63. Courtellemont L, Guinard J, Guillaume C, Giaché S, Rzepecki V, Seve A, Gubavu C, Baud K, Le Helloco C, Cassuto GN, Pialoux G, Hocqueloux L, Prazuck T. High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection. J Med Virol. 2021 Feb 21. doi: 10.1002/jmv.26896. Epub ahead of print. PMID: 33615487.
  64. Thommes L, Burkert FR, Öttl KW, Goldin D, Loacker L, Lanser L, Griesmacher A, Theurl I, Weiss G, Bellmann-Weiler R. Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients. Int J Infect Dis. 2021 Feb 17;105:144–6. doi: 10.1016/j.ijid.2021.02.052. Epub ahead of print. PMID: 33609774; PMCID: PMC7888994.
  65. Singh NK, Ray P, Carlin AF, Magallanes C, Morgan SC, Laurent LC, Aronoff-Spencer ES, Hall DA. Hitting the diagnostic sweet spot: Point-of-care SARS-CoV-2 salivary antigen testing with an off-the-shelf glucometer. Biosens Bioelectron. 2021 Feb 26;180:113111. doi: 10.1016/j.bios.2021.113111. Epub ahead of print. PMID: 33743492.
  66. Masiá M, Fernández-González M, Sánchez M, Carvajal M, García JA, Gonzalo-Jiménez N, Ortiz de la Tabla V, Agulló V, Candela I, Guijarro J, Gutiérrez JA, de Gregorio C, Gutiérrez F. Nasopharyngeal Panbio COVID-19 Antigen Performed at Point-of-Care Has a High Sensitivity in Symptomatic and Asymptomatic Patients With Higher Risk for Transmission and Older Age. Open Forum Infect Dis. 2021 Feb 2;8(3):ofab059. doi: 10.1093/ofid/ofab059. PMID: 33723512; PMCID: PMC7928615.
  67. Paltiel AD, Zheng A, Sax PE. Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission. Ann Intern Med. 2021 Mar 9. doi: 10.7326/M21-0510. Epub ahead of print. PMID: 33683930.
  68. Crozier A, Rajan S, Buchan I, McKee M. Put to the test: use of rapid testing technologies for covid-19. BMJ. 2021 Feb 3;372:n208. doi: 10.1136/bmj.n208. PMID: 33536228.
  69. Rottenstreich A, Zarbiv G, Kabiri D, Benenson S, Oster Y, Porat S, Sompolinsky Y, Reubinoff B. Rapid antigen detection testing for universal screening for SARS-CoV-2 in women admitted for delivery. Am J Obstet Gynecol. 2021 Jan 13:S0002-9378(21)00025-9. doi: 10.1016/j.ajog.2021.01.002. Epub ahead of print. PMID: 33453181.
  70. Favresse J, Gillot C, Oliveira M, Cadrobbi J, Elsen M, Eucher C, Laffineur K, Rosseels C, Van Eeckhoudt S, Nicolas JB, Morimont L, Dogné JM, Douxfils J. Head-to-Head Comparison of Rapid and Automated Antigen Detection Tests for the Diagnosis of SARS-CoV-2 Infection. J Clin Med. 2021 Jan 13;10(2):E265. doi: 10.3390/jcm10020265. PMID: 33450853.
  71. Osterman A, Baldauf HM, Eletreby M, Wettengel JM, Afridi SQ, Fuchs T, Holzmann E, Maier A, Döring J, Grzimek-Koschewa N, Muenchhoff M, Protzer U, Kaderali L, Keppler OT. Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting. Med Microbiol Immunol. 2021 Jan 16. doi: 10.1007/s00430-020-00698-8. Epub ahead of print. PMID: 33452927.
  72. Komarov A, Kaznadzey A, Li Y, Kireeva M, Mazo I. Dual-Antigen System Allows Elimination of False Positive Results in COVID-19 Serological Testing. Diagnostics (Basel). 2021 Jan 11;11(1):E102. doi: 10.3390/diagnostics11010102. PMID: 33440690.
  73. Torres I, Poujois S, Albert E, Colomina J, Navarro D. Evaluation of a rapid antigen test (Panbio™ COVID-19 Ag rapid test device) for SARS-CoV-2 detection in asymptomatic close contacts of COVID-19 patients. Clin Microbiol Infect. 2021 Jan 6:S1198-743X(20)30782-5. doi: 10.1016/j.cmi.2020.12.022. Epub ahead of print. PMID: 33421573.
  74. Okoye NC, Barker AP, Curtis K, Orlandi RR, Snavely EA, Wright C, Hanson KE, Pearson LN. Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting. J Clin Microbiol. 2021 Jan 28:JCM.03282-20. doi: 10.1128/JCM.03282-20. Epub ahead of print. PMID: 33509809.
  75. Villaverde S, Domínguez-Rodríguez S, Sabrido G, Pérez-Jorge C, Plata M, Romero MP, Grasa C, Jiménez AB, Heras E, Broncano A, Núñez M, Illán M, Merino P, Soto B, Molina-Arana D, Bermejo A, Mendoza P, Gijón M, Pérez-Moneo B, Moraleda C, Tagarro A; EPICO-AEP Working Group.. Diagnostic Accuracy of the Panbio SARS-CoV-2 Antigen Rapid Test Compared with Rt-Pcr Testing of Nasopharyngeal Samples in the Pediatric Population. J Pediatr. 2021 Jan 20:S0022-3476(21)00034-2. doi: 10.1016/j.jpeds.2021.01.027. Epub ahead of print. PMID: 33484697; PMCID: PMC7826137.
  76. Kohmer N, Toptan T, Pallas C, Karaca O, Pfeiffer A, Westhaus S, Widera M, Berger A, Hoehl S, Kammel M, Ciesek S, Rabenau HF. The Comparative Clinical Performance of Four SARS-CoV-2 Rapid Antigen Tests and Their Correlation to Infectivity In Vitro. J Clin Med. 2021 Jan 17;10(2):328. doi: 10.3390/jcm10020328. PMID: 33477365; PMCID: PMC7830733.
  77. Prince-Guerra JL, Almendares O, Nolen LD, Gunn JKL, Dale AP, Buono SA, Deutsch-Feldman M, Suppiah S, Hao L, Zeng Y, et al. Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites - Pima County, Arizona, November 3-17, 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 22;70(3):100-105. doi: 10.15585/mmwr.mm7003e3. PMID: 33476316; PMCID: PMC7821766.
  78. Fenollar, A. Bouam, M. Ballouche, L. Fuster, E. Prudent, P. Colson, H. Tissot-Dupont, M. Million, M. Drancourt, D. Raoult, P.E. Fournier, Evaluation of the panbio COVID-19 rapid antigen detection test device for the screening of patients with COVID-19, J. Clin. Microbiol. 59 (2021).
  79. Kashiwagi, Y. Ishii, K. Aoki, S. Yagi, T. Maeda, T. Miyazaki, S. Yoshizawa, K. Aoyagi, K. Tateda, Immunochromatographic test for the detection of SARS-CoV-2 in saliva, J. Infect. Chemother. 27 (2021) 384–386.
  80. Dinnes, J.J. Deeks, S. Berhane, M. Taylor, A. Adriano, C. Davenport, S. Dittrich, D. Emperador, Y. Takwoingi, J. Cunningham, S. Beese, J. Domen, J. Dretzke, L. Ferrante di Ruffano, I.M. Harris, M.J. Price, S. Taylor-Phillips, L. Hooft, M.M. Leeflang, M.D. McInnes, R. Spijker, A. Van den Bruel, Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection, Cochrane Database Syst. Rev. (2021).
  81. Ristić, N. Nikolić, V. Čabarkapa, V. Turkulov, V. Petrović, Validation of the STANDARD Q COVID-19 antigen test in Vojvodina, Serbia., PLoS One. 16 (2021) e0247606.
  82. Saeed, S.R. Uppal, Z.Z. Piracha, A. Rasheed, Z. Aftab, H. Zaheer, R. Uppal, Evaluation of SARS-CoV-2 antigen-based rapid diagnostic kits in Pakistan: formulation of COVID-19 national testing strategy, Virol. J. 18 (2021).


Serology Testing:

  1. Rapp AR, Ogunbileje JO, Djouodo-Nemzou D, Okorodudu AO. Methods matter - Tailoring SARS-CoV-2 antibody targets to vaccination status. Clin Chim Acta. 2021 Aug;519:140-141. doi: 10.1016/j.cca.2021.04.009. Epub 2021 Apr 17. PMID: 33872607; PMCID: PMC8052504.
  2. Padoan A, Dall'Olmo L, Rocca FD, Barbaro F, Cosma C, Basso D, Cattelan A, Cianci V, Plebani M. Antibody response to first and second dose of BNT162b2 in a cohort of characterized healthcare workers. Clin Chim Acta. 2021 Aug;519:60-63. doi: 10.1016/j.cca.2021.04.006. Epub 2021 Apr 20. PMID: 33857476; PMCID: PMC8056941.
  3. Raposo F, Lippi G. Antibody response induced by the boost overdose during COVID-19 heterologous prime-boost vaccination strategy. Clin Chim Acta. 2021 Sep 29;523:201-204. doi: 10.1016/j.cca.2021.09.022. Epub ahead of print. PMID: 34599902; PMCID: PMC8480142.
  4. Ferrari D, Clementi N, Spanò SM, Albitar-Nehme S, Ranno S, Colombini A, Criscuolo E, Di Resta C, Tomaiuolo R, Viganó M, Mancini N, De Vecchi E, Locatelli M, Mangia A, Perno CF, Banfi G. Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects. Clin Chim Acta. 2021 Nov;522:144-151. doi: 10.1016/j.cca.2021.08.024. Epub 2021 Aug 20. PMID: 34425105; PMCID: PMC8378065.
  5. He Y, Tong Y. A theoretical simulation of SARS-CoV-2 pooled testing: Pooled sample collection outperforms pooled RNA extraction. Clin Chim Acta. 2021 Oct;521:155-157. doi: 10.1016/j.cca.2021.07.016. Epub 2021 Jul 16. PMID: 34274344; PMCID: PMC8282448.
  6. Nandakumar V, Profaizer T, Lozier BK, Elgort MG, Rychert J, Slev PR, Delgado JC. Evaluation of a Novel Multiplex Platform for Simultaneous Detection of IgG Antibodies against the Four Main SARS-CoV-2 Antigens. J Appl Lab Med. 2021 Nov 6:jfab161. doi: 10.1093/jalm/jfab161. Epub ahead of print. PMID: 34741514.
  7. Wu AHB, Nguyen ED, Ong CM, Yun C, Lynch KL. Rate of Serum SARS-CoV-2 Antibody Decline for two mRNA Vaccines. J Appl Lab Med. 2021 Oct 14:jfab137. doi: 10.1093/jalm/jfab137. Epub ahead of print. PMID: 34648027; PMCID: PMC8524641.
  8. Jung J, Rajapakshe D, Julien C, Devaraj S. Analytical and clinical performance of cPass neutralizing antibodies assay. Clin Biochem. 2021 Sep 21:S0009-9120(21)00249-6. doi: 10.1016/j.clinbiochem.2021.09.008. Epub ahead of print. PMID: 34560062; PMCID: PMC8453782.
  9. Cook N, Xu L, Hegazy S, Wheeler BJ, Anderson AR, Critelli N, Yost M, McElroy AK, Shurin MR, Wheeler SE. Multiplex assessment of SARS-CoV-2 antibodies improves assay sensitivity and correlation with neutralizing antibodies. Clin Biochem. 2021 Nov;97:54-61. doi: 10.1016/j.clinbiochem.2021.08.006. Epub 2021 Aug 26. PMID: 34453893; PMCID: PMC8387133.
  10. Poore B, Nerenz RD, Brodis D, Brown CI, Cervinski MA, Hubbard JA. A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays. Clin Biochem. 2021 Sep;95:77-80. doi: 10.1016/j.clinbiochem.2021.05.011. Epub 2021 Jun 9. PMID: 34118242; PMCID: PMC8188801.
  11. Poore B, Nerenz RD, Brodis D, Brown CI, Cervinski MA, Hubbard JA. A comparison of SARS-CoV-2 nucleocapsid and spike antibody detection using three commercially available automated immunoassays. Clin Biochem. 2021 Sep;95:77-80. doi: 10.1016/j.clinbiochem.2021.05.011. Epub 2021 Jun 9. PMID: 34118242; PMCID: PMC8188801.
  12. Heaney CD, Pisanic N, Randad PR, Kruczynski K, Howard T, Zhu X, Littlefield K, Patel EU, Shrestha R, Laeyendecker O, Shoham S, Sullivan D, Gebo K, Hanley D, Redd AD, Quinn TC, Casadevall A, Zenilman JM, Pekosz A, Bloch EM, Tobian AAR. Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers. J Clin Virol. 2021 Oct 9;145:104997. doi: 10.1016/j.jcv.2021.104997. Epub ahead of print. PMID: 34695724; PMCID: PMC8502080.

Less recent publications on Serology Testing

  1. Suhandynata RT, Bevins NJ, Tran JT, et al. SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses. J Appl Lab Med. 2021;6(5):1109-1122. doi:10.1093/jalm/jfab080
  2. Ou J, Tan M, He H, et al. SARS-CoV-2 Antibodies and Associated Factors at Different Hospitalization Time Points in 192 COVID-19 Cases. J Appl Lab Med. 2021;6(5):1133-1142. doi:10.1093/jalm/jfab003
  3. El-Khoury JM, Schulz WL, Durant TJS. Longitudinal Assessment of SARS-CoV-2 Antinucleocapsid and Antispike-1-RBD Antibody Testing Following PCR-Detected SARS-CoV-2 Infection. J Appl Lab Med. 2021;6(4):1005-1011. doi:10.1093/jalm/jfab030
  4. Plaga A, Wei R, Olson E, et al. Evaluation of the Clinical Performance of 7 Serological Assays for SARS-CoV-2 for Use in Clinical Laboratories. J Appl Lab Med. 2021;6(4):998-1004. doi:10.1093/jalm/jfab038
  5. Mueller T. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer. Clin Chim Acta. 2021;518:9-16. doi:10.1016/j.cca.2021.03.007
  6. Ciotti M, Ciccozzi M, Pieri M, Bernardini S. The COVID-19 pandemic: viral variants and vaccine efficacy [published online ahead of print, 2021 Oct 1]. Crit Rev Clin Lab Sci. 2021;1-10. doi:10.1080/10408363.2021.1979462
  7. Lippi G, Henry BM, Plebani M. Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role? [published online ahead of print, 2021 Sep 8]. Clin Chem Lab Med. 2021;10.1515/cclm-2021-0972. doi:10.1515/cclm-2021-0972
  8. Meschi S, Matusali G, Colavita F, et al. Predicting the protective humoral response to a SARS-CoV-2 mRNA vaccine [published online ahead of print, 2021 Sep 7]. Clin Chem Lab Med. 2021;10.1515/cclm-2021-0700. doi:10.1515/cclm-2021-0700
  9. Franchini M, Mengoli C, Caruso B, Petilino R, Ballotari A, Glingani C. Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma [published online ahead of print, 2021 Sep 2]. Clin Chem Lab Med. 2021;10.1515/cclm-2021-0810. doi:10.1515/cclm-2021-0810
  10. Löfström E, Eringfält A, Kötz A, et al. Dynamics of IgG-avidity and antibody levels after Covid-19 [published online ahead of print, 2021 Sep 20]. J Clin Virol. 2021;144:104986. doi:10.1016/j.jcv.2021.104986
  11. Fischer B, Lichtenberg C, Müller L, Timm J, Fischer J, Knabbe C. A combined strategy to detect plasma samples reliably with high anti-SARS-CoV-2 neutralizing antibody titers in routine laboratories [published online ahead of print, 2021 Sep 16]. J Clin Virol. 2021;144:104984. doi:10.1016/j.jcv.2021.104984
  12. Montesinos I, Dahma H, Wolff F, Dauby N, Delaunoy S, Wuyts M, Detemmerman C, Duterme C, Vandenberg O, Martin C, Hallin M. Neutralizing antibody responses following natural SARS-CoV-2 infection: dynamics and correlation with commercial serologic tests. Journal of Clinical Virology. 2021 Sep 28:104988.
  13. Cao J, Liu X, Muthukumar A, Gagan J, Jones P, Zu Y. Poor Humoral Response in Solid Organ Transplant Recipients following Complete mRNA SARS-CoV-2 Vaccination [published online ahead of print, 2021 Aug 6]. Clin Chem. 2021;hvab149. doi:10.1093/clinchem/hvab149
  14. Müller K, Girl P, Giebl A, et al. Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2. J Clin Virol. 2021;142:104912. doi:10.1016/j.jcv.2021.104912
  15. Di Meo A, Miller JJ, Fabros A, et al. Evaluation of Three anti-SARS-CoV-2 Serologic Immunoassays for Post-Vaccine Response [published online ahead of print, 2021 Aug 3]. J Appl Lab Med. 2021;jfab087. doi:10.1093/jalm/jfab087
  16. Bohn MK, Yousef P, Steele S, Sepiashvili L, Adeli K. Multi-Inflammatory Syndrome in Children: A View into Immune Pathogenesis from a Laboratory Perspective [published online ahead of print, 2021 Aug 31]. J Appl Lab Med. 2021;jfab114. doi:10.1093/jalm/jfab114
  17. Sciacovelli L, Padoan A, Secchiero S, Plebani M. Serological diagnostic for SARS-CoV-2: an experimental External Quality Assessment Scheme. Clin Chem Lab Med. 2021;59(11):1878-1884. Published 2021 Aug 5. doi:10.1515/cclm-2021-0662
  18. Anderson M, Holzmayer V, Vallari A, Taylor R, Moy J, Cloherty G. Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays. J Clin Virol. 2021;141:104855. doi:10.1016/j.jcv.2021.104855
  19. Ong DSY, Keuren F, van der Vliet M, Boxma-de Klerk BM, Koeleman JGM. SARS-CoV-2 antibody response dynamics and heterogeneous diagnostic performance of four serological tests and a neutralization test in symptomatic healthcare workers with non-severe COVID-19. J Clin Virol. 2021;141:104904. doi:10.1016/j.jcv.2021.104904
  20. Amiral J, Busch MH, Timmermans SAMEG, Reutelingsperger CP, van Paassen P. Development of IgG, IgM, and IgA autoantibodies against angiotensin converting enzyme 2 in patients with COVID-19 [published online ahead of print, 2021 Jul 2]. J Appl Lab Med. 2021;jfab065. doi:10.1093/jalm/jfab065
  21. Nilles EJ, Karlson EW, Norman M, et al. Evaluation of three commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2 [published online ahead of print, 2021 Jul 1]. J Appl Lab Med. 2021;jfab072. doi:10.1093/jalm/jfab072
  22. Plebani M, Cosma C, Padoan A. SARS-CoV-2 antibody assay after vaccination: one size does not fit all. Clin Chem Lab Med. 2021;59(10):e380-e381. Published 2021 Jun 30. doi:10.1515/cclm-2021-0703
  23. Salvagno GL, Henry BM, Pighi L, De Nitto S, Gianfilippi GL, Lippi G. Monitoring of the immunogenic response to Pfizer BNT162b2 mRNA COVID-19 vaccination in healthcare workers with Snibe SARS-CoV-2 S-RBD IgG chemiluminescent immunoassay. Clin Chem Lab Med. 2021;59(10):e377-e379. Published 2021 Jun 23. doi:10.1515/cclm-2021-0687
  24. Yokoyama APH, et al. COVID-19 convalescent plasma cohort study: evaluation of the association between both donor and recipient neutralizing antibody titers and patient outcomes. Transfusion. 2021 Jun 26. doi: 10.1111/trf.16573. Epub ahead of print. PMID: 34173248.
  25. Heggestad JT, et al. Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test. Sci Adv. 2021 Jun 25;7(26):eabg4901. doi: 10.1126/sciadv.abg4901. PMID: 34172447.
  26. Zeng F, et al. Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients. J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27152. Epub ahead of print. PMID: 34170519.
  27. Wang R, et al. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. Immunity. 2021 Jun 8:S1074-7613(21)00247-8. doi: 10.1016/j.immuni.2021.06.003. Epub ahead of print. PMID: 34166623; PMCID: PMC8185182.
  28. Verderese JP, et al. Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience. Clin Infect Dis. 2021 Jun 24:ciab579. doi: 10.1093/cid/ciab579. Epub ahead of print. PMID: 34166513.
  29. Choe PG, et al. Persistence of Neutralizing Antibody Response up to One Year after Asymptomatic or Symptomatic SARS-CoV-2 infection. J Infect Dis. 2021 Jun 24:jiab339. doi: 10.1093/infdis/jiab339. Epub ahead of print. PMID: 34166506.
  30. Theel ES, et al. SARS-CoV-2 Serologic Assays Dependent on Dual-Antigen Binding Demonstrate Diverging Kinetics Relative to Other Antibody Detection Methods. J Clin Microbiol. 2021 Jun 24:JCM0123121. doi: 10.1128/JCM.01231-21. Epub ahead of print. PMID: 34166066.
  31. Bradley BT, et al. Anti-SARS-CoV-2 antibody levels measured by the Advise Dx SARS-CoV-2 assay are concordant with previously available serologic assays but are not fully predictive of sterilizing immunity. J Clin Microbiol. 2021 Jun 24:JCM0098921. doi: 10.1128/JCM.00989-21. Epub ahead of print. PMID: 34165323.
  32. Jamiruddin MR, et al. Longitudinal Antibody Dynamics Against Structural Proteins of SARS-CoV-2 in Three COVID-19 Patients Shows Concurrent Development of IgA, IgM, and IgG. J Inflamm Res. 2021 Jun 14;14:2497-2506. doi: 10.2147/JIR.S313188. PMID: 34163208; PMCID: PMC8214341.
  33. Kamaladasa A, et al. Comparison of two assays to detect IgG antibodies to the receptor binding domain of the SARS‑CoV‑2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients. Int J Infect Dis. 2021 Jun 20:S1201-9712(21)00520-8. doi: 10.1016/j.ijid.2021.06.031. Epub ahead of print. PMID: 34161801; PMCID: PMC8214815.
  34. Sharwani K, et al. Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in pre-pandemic and post-COVID-19 convalescent samples. J Infect Dis. 2021 Jun 23:jiab333. doi: 10.1093/infdis/jiab333. Epub ahead of print. PMID: 34161567.
  35. Bonfante F, et al. Mild SARS-CoV-2 Infections and Neutralizing Antibody Titers. Pediatrics. 2021 Jun 22:e2021052173. doi: 10.1542/peds.2021-052173. Epub ahead of print. PMID: 34158312.
  36. Kyosei Y, et al. Improved detection sensitivity of an antigen test for SARS-CoV-2 nucleocapsid proteins with thio-NAD cycling. Biol Pharm Bull. 2021 Jun 19. doi: 10.1248/bpb.b21-00387. Epub ahead of print. PMID: 34148926.
  37. Wang H, et al Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results. Clin Chem. 2021 Mar 15:hvab045. doi: 10.1093/clinchem/hvab045. Epub ahead of print. PMID: 33720347; PMCID: PMC7989591.
  38. Vengesai A, Midzi H, Kasambala M, Mutandadzi H, Mduluza-Jokonya TL, Rusakaniko S, Mutapi F, Naicker T, Mduluza T. A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19. Syst Rev. 2021 May 26;10(1):155. doi: 10.1186/s13643-021-01689-3. PMID: 34039423; PMCID: PMC8152206.
  39. Le Vu S, Jones G, Anna F, Rose T, Richard JB, Bernard-Stoecklin S, Goyard S, Demeret C, Helynck O, Escriou N, Gransagne M, Petres S, Robin C, Monnet V, Perrin de Facci L, Ungeheuer MN, Léon L, Guillois Y, Filleul L, Charneau P, Lévy-Bruhl D, van der Werf S, Noel H. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Nat Commun. 2021 May 21;12(1):3025. doi: 10.1038/s41467-021-23233-6. PMID: 34021152.
  40. Whitaker HJ, Elgohari S, Rowe C, Otter AD, Brooks T, Linley E, Hayden I, Ribeiro S, Hewson J, Lakhani A, Clarke E, Tsang C, Campbell CN, Ramsay M, Brown K, Amirthalingam G. Impact of COVID-19 vaccination program on seroprevalence in blood donors in England, 2021. J Infect. 2021 May 11:S0163-4453(21)00224-3. doi: 10.1016/j.jinf.2021.04.037. Epub ahead of print. PMID: 33989631; PMCID: PMC8110696.
  41. Soffer S, Glicksberg BS, Zimlichman E, Efros O, Levin MA, Freeman R, Reich DL, Klang E. The Association Between Obesity and Peak Antibody Titer Response in COVID-19 Infection. Obesity (Silver Spring). 2021 May 4. doi: 10.1002/oby.23208. Epub ahead of print. PMID: 33945220.
  42. Bubonja-Šonje M, Batičić L, Abram M, Cekinović Grbeša Đ. Diagnostic accuracy of three SARS-CoV2 antibody detection assays, neutralizing effect and longevity of serum antibodies. J Virol Methods. 2021 Jul;293:114173. doi: 10.1016/j.jviromet.2021.114173. Epub 2021 Apr 27. PMID: 33930473; PMCID: PMC8078047.
  43. Tollånes MC, Jenum PA, Kierkegaard H, Abildsnes E, Bævre-Jensen RM, Breivik AC, Sandberg S. Evaluation of 32 rapid tests for detection of antibodies against SARS-CoV-2. Clin Chim Acta. 2021 Apr 27;519:133-139. doi: 10.1016/j.cca.2021.04.016. Epub ahead of print. PMID: 33930425; PMCID: PMC8078036.
  44. Werner M, Pervan P, Glück V, Zeman F, Koller M, Burkhardt R, Glück T, Wenzel JJ, Schmidt B, Gessner A, Peterhoff D. Evaluation of a Broad Panel of SARS-CoV-2 Serological Tests for Diagnostic Use. J Clin Med. 2021 Apr 8;10(8):1580. doi: 10.3390/jcm10081580. PMID: 33918081; PMCID: PMC8070215.
  45. Florin L, Maelegheer K, Vandewal W, Bernard D, Robbrecht J. Performance Evaluation of the Siemens SARS-CoV-2 Total Antibody and IgG Antibody Test. Lab Med. 2021 Apr 30:lmab027. doi: 10.1093/labmed/lmab027. Epub ahead of print. PMID: 33928377.
  46. Jin DK, Nesbitt DJ, Yang J, Chen H, Horowitz J, Jones M, Vandergaast R, Carey T, Reiter S, Russell SJ, Kyratsous C, Hooper A, Hamilton J, Ferreira M, Deng S, Straus D, Baras A, Hillyer CD, Luchsinger LL. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening". PLoS One. 2021 Apr 28;16(4):e0250319. doi: 10.1371/journal.pone.0250319. PMID: 33909646.
  47. Jalkanen P, Pasternack A, Maljanen S, Melén K, Kolehmainen P, Huttunen M, Lundberg R, Tripathi L, Khan H, Ritvos MA, Naves R, Haveri A, Österlund P, Kuivanen S, Jääskeläinen AJ, Kurkela S, Lappalainen M, Rantasärkkä K, Vuorinen T, Hytönen J, Waris M, Tauriainen S, Ritvos O, Kakkola L, Julkunen I. A combination of N and S antigens with IgA and IgG measurement strengthens the accuracy of SARS-CoV-2 serodiagnostics. J Infect Dis. 2021 Apr 27:jiab222. doi: 10.1093/infdis/jiab222. Epub ahead of print. PMID: 33905505.
  48. Zhou X, Ma F, Xie J, Yuan M, Li Y, Shaabani N, Zhao F, Huang D, Wu NC, Lee CD, Liu H, Li J, Chen Z, Hong Y, Liu WH, Xiao N, Burton DR, Tu H, Li H, Chen X, Teijaro JR, Wilson IA, Xiao C, Huang Z. Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2. Cell Rep. 2021 Apr 24:109109. doi: 10.1016/j.celrep.2021.109109. Epub ahead of print. PMID: 33932326.
  49. Padoan A, Bonfante F, Cosma C, Di Chiara C, Sciacovelli L, Pagliari M, Bortolami A, Costenaro P, Musso G, Basso D, Giaquinto C, Plebani M. Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: comparison with neutralization titers. Clin Chem Lab Med. 2021 Apr 13. doi: 10.1515/cclm-2021-0313. Epub ahead of print. PMID: 33855843.
  50. Matusali G, Colavita F, Lapa D, Meschi S, Bordi L, Piselli P, Gagliardini R, Corpolongo A, Nicastri E, Antinori A, Ippolito G, Capobianchi MR, Castilletti C, Inmi Covid-Laboratory Team. SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus. Viruses. 2021 Apr 10;13(4):655. doi: 10.3390/v13040655. PMID: 33920222; PMCID: PMC8069482.
  51. Andrey DO, Yerly S, Meyer B, Arm-Vernez I, Roux-Lombard P, Togni G, Guessous I, Spechbach H, Stringhini S, Agoritsas T, Stirnemann J, Reny JL, Siegrist CA, Eckerle I, Kaiser L, Vuilleumier N. Head-to-Head Evaluation of Five Automated SARS-CoV-2 Serology Immunoassays in Various Prevalence Settings. J Clin Med. 2021 Apr 10;10(8):1605. doi: 10.3390/jcm10081605. PMID: 33920076; PMCID: PMC8069412.
  52. Sibai M, Solis D, Röltgen K, Stevens BA, Mfuh KO, Sahoo MK, Shi RZ, Zehnder J, Boyd SD, Pinsky BA. Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay. J Clin Virol. 2021 Apr 1;139:104818. doi: 10.1016/j.jcv.2021.104818. Epub ahead of print. PMID: 33932848.
  53. Nagura-Ikeda M, Imai K, Kubota K, Noguchi S, Kitagawa Y, Matsuoka M, Tabata S, Miyoshi K, Ito T, Tamura K, Maeda T. Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan. J Med Microbiol. 2021 Apr;70(4). doi: 10.1099/jmm.0.001291. PMID: 33861191.
  54. Orner EP, Rodgers MA, Hock K, Tang MS, Taylor R, Gardiner M, Olivo A, Fox A, Prostko J, Cloherty G, Farnsworth CW. Comparison of SARS-CoV-2 IgM and IgG seroconversion profiles among hospitalized patients in two US cities. Diagn Microbiol Infect Dis. 2021 Apr;99(4):115300. doi: 10.1016/j.diagmicrobio.2020.115300. Epub 2020 Dec 24. PMID: 33388575; PMCID: PMC7759125.
  55. Irsara C, Egger AE, Prokop W, Nairz M, Loacker L, Sahanic S, Pizzini A, Sonnweber T, Holzer B, Mayer W, Schennach H, Loeffler-Ragg J, Bellmann-Weiler R, Hartmann B, Tancevski I, Weiss G, Binder CJ, Anliker M, Griesmacher A, Hoermann G. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers. Clin Chem Lab Med. 2021 Apr 9. doi: 10.1515/cclm-2021-0214.
  56. Brown L, Byrne RL, Fraser A, Owen SI, Cubas-Atienzar AI, Williams CT, Kay GA, Cuevas LE, Fitchett JRA, Fletcher T, Garrod G, Kontogianni K, Krishna S, Menzies S, Planche T, Sainter C, Staines HM, Turtle L, Adams ER. Self-sampling of capillary blood for SARS-CoV-2 serology. Sci Rep. 2021 Apr 8;11(1):7754. doi: 10.1038/s41598-021-86008-5
  57. Narasimhan M, Mahimainathan L, Araj E, Clark AE, Markantonis J, Green A, Xu J, SoRelle JA, Alexis C, Fankhauser K, Parikh H, Wilkinson K, Reczek A, Kopplin N, Yekkaluri S, Balani J, Thomas A, Singal AG, Sarode R, Muthukumar A. Clinical evaluation of the Abbott Alinity SARS-CoV-2 spike-specific quantitative IgG and IgM assays among infected, recovered, and vaccinated groups. J Clin Microbiol. 2021 Apr 7:JCM.00388-21. doi: 10.1128/JCM.00388-21
  58. Sweeney N, Merrick B, Pedro Galão R, Pickering S, Botgros A, Wilson HD, Signell AW, Betancor G, Tan MKI, Ramble J, Kouphou N, Acors S, Graham C, Seow J, MacMahon E, Neil SJD, Malim MH, Doores K, Douthwaite S, Batra R, Nebbia G, Edgeworth JD. Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave. PLoS One. 2021 Apr 7;16(4):e0249791. doi: 10.1371/journal.pone.0249791
  59. Plaga A, Wei R, Olson E, Payto D, Harrington J, Nwe-Kissig PT, Strizzi M, Zilka S, Ko J, Colón-Franco JM. Evaluation of the clinical performance of seven serological assays for SARS-CoV-2 for use in clinical laboratories. J Appl Lab Med. 2021 Apr 7:jfab038. doi: 10.1093/jalm/jfab038.
  60. Freeman J, Conklin J, Oramus D, Cycon K. Serology testing demonstrates that antibodies to SARS-CoV-2 S1-RBD correlate with neutralization of virus infection of Vero E6 cells. J Appl Lab Med. 2021 Apr 2:jfab027. doi: 10.1093/jalm/jfab027.
  61. Forest SK, Orner EP, Goldstein DY, Wirchnianski AS, Bortz RH, Laudermilch E, Florez C, Malonis RJ, Georgiev GI, Vergnolle O, Lo Y, Campbell ST, Barnhill J, Cadoff EM, Lai JR, Chandran K, Weiss LM, Fox AS, Prystowsky MB, Wolgast LR. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Qualitative IgG Assays: The Value of Numeric Reporting. Arch Pathol Lab Med. 2021 Apr 5. doi: 10.5858/arpa.2020-0851-SA.
  62. Sermet-Gaudelus I, Temmam S, Huon C, Behillil S, Gajdos V, Bigot T, Lurier T, Chrétien D, Backovic M, Delaunay-Moisan A, Donati F, Albert M, Foucaud E, Mesplées B, Benoist G, Faye A, Duval-Arnould M, Cretolle C, Charbit M, Aubart M, Auriau J, Lorrot M, Kariyawasam D, Fertitta L, Orliaguet G, Pigneur B, Bader-Meunier B, Briand C, Enouf V, Toubiana J, Guilleminot T, van der Werf S, Leruez-Ville M, Eloit M. Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020. Euro Surveill. 2021 Apr;26(13):2001782. doi: 10.2807/1560-7917.ES.2021.26.13.2001782.
  63. Higgins V, Fabros A, Wang XY, Bhandari M, Daghfal DJ, Kulasingam V. Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course. Clin Biochem. 2021 Jan 19:S0009-9120(21)00004-7. doi: 10.1016/j.clinbiochem.2021.01.003. Epub ahead of print. PMID: 33476578; PMCID: PMC7816645.
  64. Moshe M, Daunt A, Flower B, Simmons B, Brown JC, Frise R, Penn R, Kugathasan R, Petersen C, Stockmann H, Ashby D, Riley S, Atchison C, Taylor GP, Satkunarajah S, Naar L, Klaber R, Badhan A, Rosadas C, Marchesin F, Fernandez N, Sureda-Vives M, Cheeseman H, O'Hara J, Shattock R, Fontana G, Pallett SJC, Rayment M, Jones R, Moore LSP, Ashrafian H, Cherapanov P, Tedder R, McClure M, Ward H, Darzi A, Elliott P, Cooke GS, Barclay WS; React study team. SARS-CoV-2 lateral flow assays for possible use in national covid-19 seroprevalence surveys (React 2): diagnostic accuracy study. BMJ. 2021 Mar 2;372:n423. doi: 10.1136/bmj.n423. PMID: 33653694; PMCID: PMC7921617.
  65. Subramanian R, He Q, Pascual M. Quantifying asymptomatic infection and transmission of COVID-19 in New York City using observed cases, serology, and testing capacity. Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):e2019716118. doi: 10.1073/pnas.2019716118. PMID: 33571106.
  66. Edouard S, Jaafar R, Orain N, Parola P, Colson P, La Scola B, Fournier PE, Raoult D, Drancourt M. Automated Western immunoblotting detection of anti-SARS-CoV-2 serum antibodies. Eur J Clin Microbiol Infect Dis. 2021 Mar 3:1–9. doi: 10.1007/s10096-021-04203-8. Epub ahead of print. PMID: 33660134; PMCID: PMC7928199.
  67. Patil HP, Rane PS, Shrivastava S, Palkar S, Lalwani S, Mishra AC, Arankalle VA. Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients. Viral Immunol. 2021 Mar 3. doi: 10.1089/vim.2020.0321. Epub ahead of print. PMID: 33656935.
  68. Gasser R, Cloutier M, Prévost J, Fink C, Ducas É, Ding S, Dussault N, Landry P, Tremblay T, Laforce-Lavoie A, Lewin A, Beaudoin-Bussières G, Laumaea A, Medjahed H, Larochelle C, Richard J, Dekaban GA, Dikeakos JD, Bazin R, Finzi A. Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2. Cell Rep. 2021 Mar 2;34(9):108790. doi: 10.1016/j.celrep.2021.108790. Epub 2021 Feb 10. PMID: 33596407; PMCID: PMC7874916.
  69. Hanssen DAT, Slaats M, Mulder M, Savelkoul PHM, van Loo IHM. Evaluation of 18 commercial serological assays for the detection of antibodies against SARS-CoV-2 in paired serum samples. Eur J Clin Microbiol Infect Dis. 2021 Mar 17:1–9. doi: 10.1007/s10096-021-04220-7. Epub ahead of print. PMID: 33733395; PMCID: PMC7968571.
  70. Needle R, Gilbert L, Zahariadis G, Yu Y, Dalton-Kenny H, Russell RS, Wang P, Donovan C, Hookey S, Jiao L. Serological Evaluation of Human Antibodies of the Immunoglobulin Class A and G Against SARS-CoV-2 in Serum Collected in Newfoundland and Labrador. Viral Immunol. 2021 Mar 18. doi: 10.1089/vim.2020.0199. Epub ahead of print. PMID: 33739895.
  71. Pallett SJC, Denny SJ, Patel A, Charani E, Mughal N, Stebbing J, Davies GW, Moore LSP. Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population. Sci Rep. 2021 Mar 12;11(1):5860. doi: 10.1038/s41598-021-85247-w. PMID: 33712679; PMCID: PMC7955061.
  72. Garritsen A, Scholzen A, van den Nieuwenhof DWA, Smits APF, Datema ES, van Galen LS, Kouwijzer MLCE. Two-tiered SARS-CoV-2 seroconversion screening in the Netherlands and stability of nucleocapsid, spike protein domain 1 and neutralizing antibodies. Infect Dis (Lond). 2021 Mar 8:1-15. doi: 10.1080/23744235.2021.1893378. Epub ahead of print. PMID: 33684020; PMCID: PMC7967720.
  73. Bonelli F, Blocki FA, Bunnell T, Chu E, De La O A, Grenache DG, Marzucchi G, Montomoli E, Okoye L, Pallavicini L, Streva VA, Torelli A, Wagner A, Zanin D, Zierold C, Wassenberg JJ. Evaluation of the automated LIAISON®SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies. Clin Chem Lab Med. 2021 Mar 12. doi: 10.1515/cclm-2021-0023. Epub ahead of print. PMID: 33711225.
  74. Kierkegaard P, McLister A, Buckle P. Rapid point-of-care testing for COVID-19: quality of supportive information for lateral flow serology assays. BMJ Open. 2021 Mar 19;11(3):e047163. doi: 10.1136/bmjopen-2020-047163. PMID: 33741675.
  75. Arkhipova-Jenkins I, Helfand M, Armstrong C, Gean E, Anderson J, Paynter RA, Mackey K. Antibody Response After SARS-CoV-2 Infection and Implications for Immunity : A Rapid Living Review. Ann Intern Med. 2021 Mar 16. doi: 10.7326/M20-7547. Epub ahead of print. PMID: 33721517.
  76. Noh JY, Kwak JE, Yang JS, Hwang SY, Yoon JG, Seong H, Hyun H, Lim CS, Yoon SY, Ryou J, Lee JY, Kim SS, Park SH, Cheong HJ, Kim WJ, Shin EC, Song JY. Longitudinal assessment of anti-SARS-CoV-2 immune responses for six months based on the clinical severity of COVID-19. J Infect Dis. 2021 Mar 4:jiab124. doi: 10.1093/infdis/jiab124. Epub ahead of print. PMID: 33686421.
  77. Tian L, Elsheikh EB, Patrone PN, Kearsley AJ, Gaigalas AK, Inwood S, Lin-Gibson S, Esposito D, Wang L. Towards Quantitative and Standardized Serological and Neutralization Assays for COVID-19. Int J Mol Sci. 2021 Mar 8;22(5):2723. doi: 10.3390/ijms22052723.
  78. Focosi D, Franchini M. Clinical Predictors Of SARS-CoV-2 Neutralizing Antibody Titers In COVID-19 Convalescents: Implications For Convalescent Plasma Donor Recruitment. Eur J Haematol. 2021 Mar 29. doi: 10.1111/ejh.13630. Epub ahead of print. PMID: 33780551.
  79. Cook AM, Faustini SE, Williams LJ, Cunningham AF, Drayson MT, Shields AM, Kay D, Taylor L, Plant T, Huissoon A, Wallis G, Beck S, Jossi SE, Perez-Toledo M, Newby ML, Allen JD, Crispin M, Harding S, Richter AG. Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients. J Immunol Methods. 2021 Mar 26;494:113046. doi: 10.1016/j.jim.2021.113046.
  80. Tang MS, Farnsworth CW. Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands. Clin Chem. 2021 Mar 27:hvab039. doi: 10.1093/clinchem/hvab039.
  81. Wehrhahn MC, Brown SJ, Newcombe JP, Chong S, Evans J, Figtree M, Hainke L, Hueston L, Khan S, Marland E, O'Sullivan MVN, Powell H, Roy J, Waring L, Yu M, Robson J. An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population. J Clin Virol. 2021 Mar 17;138:104797. doi: 10.1016/j.jcv.2021.104797.
  82. Zhang YV, Wiencek J, Meng QH, Theel ES, Babic N, Sepiashvili L, Pecora ND, Slev P, Cameron A, Konforte D; AACC COVID 19 Serologic Testing Task Force. AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 EUA and LDT Serologic Testing in Clinical Laboratories. Clin Chem. 2021 Mar 24:hvab051. doi: 10.1093/clinchem/hvab051.
  83. Demonbreun AR, McDade TW, Pesce LL, Vaught LA, Reiser NL, Bogdanovic E, Velez MP, Hsieh RR, Simons LM, Saber R, Ryan DT, Ison MG, Hultquist JF, Wilkins JT, D'Aquila RT, Mustanski B, McNally EM. Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure. JCI Insight. 2021 Mar 23:146148. doi: 10.1172/jci.insight.146148.
  84. Yang HS, Costa V, Racine-Brzostek SE, Acker KP, Yee J, Chen Z, Karbaschi M, Zuk R, Rand S, Sukhu A, Klasse PJ, Cushing MM, Chadburn A, Zhao Z. Association of Age With SARS-CoV-2 Antibody Response. JAMA Netw Open. 2021 Mar 1;4(3):e214302. doi:10.1001/jamanetworkopen.2021.4302.
  85. Zhang JJY, Lee KS, Ong CW, Chan MY, Ang LW, Leo YS, Chen MI, Lye DCB, Young BE. Diagnostic performance of COVID-19 serological assays during early infection: A systematic review and meta-analysis of 11 516 samples. Influenza Other Respir Viruses. 2021 Feb 20. doi: 10.1111/irv.12841. Epub ahead of print. PMID: 33609075.
  86. Becker M, Strengert M, Junker D, Kaiser PD, Kerrinnes T, Traenkle B, Dinter H, Häring J, Ghozzi S, Zeck A, Weise F, Peter A, Hörber S, Fink S, Ruoff F, Dulovic A, Bakchoul T, Baillot A, Lohse S, Cornberg M, Illig T, Gottlieb J, Smola S, Karch A, Berger K, Rammensee HG, Schenke-Layland K, Nelde A, Märklin M, Heitmann JS, Walz JS, Templin M, Joos TO, Rothbauer U, Krause G, Schneiderhan-Marra N. Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity. Nat Commun. 2021 Feb 19;12(1):1152. doi: 10.1038/s41467-021-20973-3. PMID: 33608538.
  87. Haguet H, Douxfils J, Eucher C, Elsen M, Cadrobbi J, Tré-Hardy M, Dogné JM, Favresse J. Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients. J Med Virol. 2021 Feb 18. doi: 10.1002/jmv.26884. Epub ahead of print. PMID: 33599299.
  88. Piec I, English E, Thomas MA, Dervisevic S, Fraser WD, John WG. Performance of SARS-CoV-2 serology tests: Are they good enough? PLoS One. 2021 Feb 17;16(2):e0245914. doi: 10.1371/journal.pone.0245914. PMID: 33596236.
  89. Fiore BD, Paola L, Eugenio M, Gaetano B, Anna V, Antonella L, Annalisa S, Laura M. Anti-Spike S1 Receptor-Binding Domain Antibodies against SARS-CoV-2 Persist Several Months after Infection Regardless of Disease Severity. J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26878. Epub ahead of print. PMID: 33590900.
  90. Mulchandani R, Brown B, Brooks T, Semper A, Machin N, Linley E, Borrow R, Wyllie D; EDSAB-HOME Study Investigators. Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay. J Clin Virol. 2021 Jan 19;136:104739. doi: 10.1016/j.jcv.2021.104739. Epub ahead of print. PMID: 33588354; PMCID:
  91. Ebinger JE, Botwin GJ, Albert CM, Alotaibi M, Arditi M, Berg AH, Binek A, Botting P, Fert-Bober J, Figueiredo JC, Grein JD, Hasan W, Henglin M, Hussain SK, Jain M, Joung S, Karin M, Kim EH, Li D, Liu Y, Luong E, McGovern DPB, Merchant A, Merin N, Miles PB, Minissian M, Nguyen TT, Raedschelders K, Rashid MA, Riera CE, Riggs RV, Sharma S, Sternbach S, Sun N, Tourtellotte WG, Van Eyk JE, Sobhani K, Braun JG, Cheng S. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers: a cross-sectional study. BMJ Open. 2021 Feb 12;11(2):e043584. doi: 10.1136/bmjopen-2020-043584. PMID: 33579769; PMCID: PMC7883610.
  92. Walker GJ, Naing Z, Ospina Stella A, Yeang M, Caguicla J, Ramachandran V, Isaacs SR, Agapiou D, Bull RA, Stelzer-Braid S, Daly J, Gosbell IB, Hoad VC, Irving DO, Pink JM, Turville S, Kelleher AD, Rawlinson WD. SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays. Viruses. 2021 Feb 4;13(2):247. doi: 10.3390/v13020247. PMID: 33557418.
  93. Wakita M, Idei M, Saito K, Horiuchi Y, Yamatani K, Ishikawa S, Yamamoto T, Igawa G, Hinata M, Kadota K, Kurosawa T, Takahashi S, Saito T, Misawa S, Akazawa C, Naito T, Miida T, Takahashi K, Ai T, Tabe Y. Comparison of the clinical performance and usefulness of five SARS-CoV-2 antibody tests. PLoS One. 2021 Feb 8;16(2):e0246536. doi: 10.1371/journal.pone.0246536. PMID: 33556086; PMCID: PMC7870088.
  94. Jeffery-Smith A, Iyanger N, Williams SV, Chow JY, Aiano F, Hoschler K, Lackenby A, Ellis J, Platt S, Miah S, Brown K, Amirthalingam G, Patel M, Ramsay ME, Gopal R, Charlett A, Ladhani SN, Zambon M. Antibodies to SARS-CoV-2 protect against re-infection during outbreaks in care homes, September and October 2020. Euro Surveill. 2021 Feb;26(5):2100092. doi: 10.2807/1560-7917.ES.2021.26.5.2100092. PMID: 33541486; PMCID: PMC7863231.
  95. Thomas SN, Altawallbeh G, Zaun CP, Pape KA, Peters JM, Titcombe PJ, Dileepan T, Rapp MJ, Bold TD, Schacker TW, Arbefeville S, Ferrieri P, Thyagarajan B, Jenkins MK, Karger AB. Initial determination of COVID-19 seroprevalence among outpatients and healthcare workers in Minnesota using a novel SARS-CoV-2 total antibody ELISA. Clin Biochem. 2021 Feb 1:S0009-9120(21)00027-8. doi: 10.1016/j.clinbiochem.2021.01.010. Epub ahead of print. PMID: 33539808; PMCID: PMC7849522.
  96. Müller L, Ostermann PN, Walker A, Wienemann T, Mertens A, Adams O, Andree M, Hauka S, Lübke N, Keitel V, Drexler I, Di Cristanziano V, Hermsen DF, Kaiser R, Boege F, Klein F, Schaal H, Timm J, Senff T. Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting. Eur J Clin Microbiol Infect Dis. 2021 Feb 3:1–9. doi: 10.1007/s10096-021-04169-7. Epub ahead of print. PMID: 33534090; PMCID: PMC7856849.
  97. Rodriguez A, Arrizabalaga M, Fernandez-Baca V, Lainez MP, Al Nakeeb Z, Garcia JD, Payeras A. Seroprevalence of SARS-CoV-2 antibody among healthcare workers in a university hospital in Mallorca, Spain, during the first wave of COVID-19 pandemic. Int J Infect Dis. 2021 Feb 26:S1201-9712(21)00190-9. doi: 10.1016/j.ijid.2021.02.104. Epub ahead of print. PMID: 33647507; PMCID: PMC7910131.
  98. Lim T, Delorey M, Bestul N, Johannsen M, Reed C, Hall AJ, Fry AM, Edens C, Semenova V, Li H, Browning P, Desai R, Epperson M, Jia T, Thornburg NJ, Schiffer J, Havers FP. Changes in SARS CoV-2 Seroprevalence Over Time in Ten Sites in the United States, March - August, 2020. Clin Infect Dis. 2021 Feb 26:ciab185. doi: 10.1093/cid/ciab185. Epub ahead of print. PMID: 33639620.
  99. Sakharkar M, Rappazzo CG, Wieland-Alter WF, Hsieh CL, Wrapp D, Esterman ES, Kaku CI, Wec AZ, Geoghegan JC, McLellan JS, Connor RI, Wright PF, Walker LM. Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol. 2021 Feb 23;6(56):eabg6916. doi: 10.1126/sciimmunol.abg6916. PMID: 33622975.
  100. Lombardi A, Mangioni D, Consonni D, Cariani L, Bono P, Cantù AP, Tiso B, Carugno M, Muscatello A, Lunghi G, Pesatori AC, Riboldi L, Ceriotti F, Bandera A, Gori A. Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study. BMJ Open. 2021 Feb 22;11(2):e047216. doi: 10.1136/bmjopen-2020-047216. PMID: 33619203; PMCID: PMC7902322.
  101. Wendel S, Fontão-Wendel R, Fachini R, Candelaria G, Scuracchio P, Achkar R, Brito M, Reis LF, Camargo A, Amano M, Machado R, Araujo D, Soares C, Durigon E. A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti-nucleocapsid (NP) SARS-CoV-2 antibody kinetics: Proposals for better quality of CCP collections. Transfusion. 2021 Feb 19. doi: 10.1111/trf.16323. Epub ahead of print. PMID: 33604884.
  102. Semmler G, Traugott MT, Graninger M, Hoepler W, Seitz T, Kelani H, Karolyi M, Pawelka E, Aragón de La Cruz S, Puchhammer-Stöckl E, Aberle SW, Stiasny K, Zoufaly A, Aberle JH, Weseslindtner L. Assessment of S1, S2 and NCP-specific IgM, IgA, and IgG antibody kinetics in acute SARS-CoV-2 infection by a microarray and twelve other immunoassays. J Clin Microbiol. 2021 Feb 18:JCM.02890-20. doi: 10.1128/JCM.02890-20. Epub ahead of print. PMID: 33602698.
  103. Rowntree LC, Chua BY, Nicholson S, Koutsakos M, Hensen L, Douros C, Selva K, Mordant FL, Wong CY, Habel JR, Zhang W, Jia X, Allen L, Doolan DL, Jackson DC, Wheatley AK, Kent SJ, Amanat F, Krammer F, Subbarao K, Cheng AC, Chung AW, Catton M, Nguyen TH, van de Sandt CE, Kedzierska K. Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features. Clin Transl Immunology. 2021 Feb 28;10(3):e1258. doi: 10.1002/cti2.1258. PMID: 33680466; PMCID: PMC7916820.
  104. Zhang JJY, Lee KS, Ong CW, Chan MY, Ang LW, Leo YS, Chen MI, Lye DCB, Young BE. Diagnostic performance of COVID-19 serological assays during early infection: A systematic review and meta-analysis of 11 516 samples. Influenza Other Respir Viruses. 2021 Feb 20. doi: 10.1111/irv.12841. Epub ahead of print. PMID: 33609075.
  105. Billon-Denis E, Ferrier-Rembert A, Garnier A, Cheutin L, Vigne C, Tessier E, Denis J, Badaut C, Rougeaux C, Depeille Wuille A, Timera H, Boutin LI, Drouet I, Verguet N, Nolent F, Gorgé O, Ferraris O, Tournier JN. Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain. Infection. 2021 Jan 2. doi: 10.1007/s15010-020-01556-8. Epub ahead of print. PMID: 33387262.
  106. He J, Huang JR, Zhang YL, Zhang J. SARS-CoV-2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice. J Med Virol. 2021 Jan 2. doi: 10.1002/jmv.26769. Epub ahead of print. PMID: 33386773.
  107. Shen Y, Ba Y, Hu Y, Wang L, Li W. Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge. Inflamm Res. 2021 Jan 1. doi: 10.1007/s00011-020-01429-8. Epub ahead of print. PMID: 33385239.
  108. Dörschug A, Schwanbeck J, Hahn A, Hillebrecht A, Blaschke S, Mese K, Groß U, Dierks S, Frickmann H, Zautner AE. Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies. Diagnostics (Basel). 2021 Jan 6;11(1):E78. doi: 10.3390/diagnostics11010078. PMID: 33418886.
  109. Li L, Tan C, Zeng J, Luo C, Hu S, Peng Y, Li W, Xie Z, Ling Y, Zhang X, Deng E, Xu H, Wang J, Xie Y, Zhou Y, Zhang W, Guo Y, Liu Z. Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients. J Transl Med. 2021 Jan 7;19(1):30. doi: 10.1186/s12967-020-02693-2. PMID: 33413461; PMCID: PMC7790347.
  110. Bolotin S, Tran V, Osman S, Brown KA, Buchan SA, Joh E, Deeks SL, Allen VG. SARS-CoV-2 seroprevalence survey estimates are affected by anti-nucleocapsid antibody decline. J Infect Dis. 2021 Jan 5:jiaa796. doi: 10.1093/infdis/jiaa796. Epub ahead of print. PMID: 33400794.
  111. Lumley SF, Wei J, O'Donnell D, Stoesser NE, Matthews PC, Howarth A, Hatch SB, Marsden BD, Cox S, James T, Peck LJ, Ritter TG, de Toledo Z, Cornall RJ, Jones EY, Stuart DI, Screaton G, Ebner D, Hoosdally S, Crook DW, Conlon CP, Pouwels KB, Walker AS, Peto TEA, Walker TM, Jeffery K, Eyre DW; Oxford University Hospitals Staff Testing Group. The duration, dynamics and determinants of SARS-CoV-2 antibody responses in individual healthcare workers. Clin Infect Dis. 2021 Jan 6:ciab004. doi: 10.1093/cid/ciab004. Epub ahead of print. PMID: 33400782.
  112. Klumpp-Thomas C, Kalish H, Drew M, Hunsberger S, Snead K, Fay MP, Mehalko J, Shunmugavel A, Wall V, Frank P, Denson JP, Hong M, Gulten G, Messing S, Hicks J, Michael S, Gillette W, Hall MD, Memoli MJ, Esposito D, Sadtler K. Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling. Nat Commun. 2021 Jan 4;12(1):113. doi: 10.1038/s41467-020-20383-x. PMID: 33397956; PMCID: PMC7782755.
  113. Lau EHY, Tsang OTY, Hui DSC, Kwan MYW, Chan WH, Chiu SS, Ko RLW, Chan KH, Cheng SMS, Perera RAPM, Cowling BJ, Poon LLM, Peiris M. Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun. 2021 Jan 4;12(1):63. doi: 10.1038/s41467-020-20247-4. PMID: 33397909; PMCID: PMC7782739.
  114. de Assis RR, Jain A, Nakajima R, Jasinskas A, Felgner J, Obiero JM, Norris PJ, Stone M, Simmons G, Bagri A, Irsch J, Schreiber M, Buser A, Holbro A, Battegay M, Hosimer P, Noesen C, Adenaiye O, Tai S, Hong F, Milton DK, Davies DH, Contestable P, Corash LM, Busch MP, Felgner PL, Khan S. Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray. Nat Commun. 2021 Jan 4;12(1):6. doi: 10.1038/s41467-020-20095-2. PMID: 33397903; PMCID: PMC7782488.
  115. Weinberger T, Steffen J, Osterman A, Mueller TT, Muenchhoff M, Wratil PR, Graf A, Krebs S, Quartucci C, Spaeth PM, Grabein B, Adorjan K, Blum H, Keppler OT, Klein M. Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany. Clin Infect Dis. 2021 Jan 3:ciaa1935. doi: 10.1093/cid/ciaa1935. Epub ahead of print. PMID: 33388756.
  116. Bohn MK, Hall A, Wilson S, Taher J, Sepiashvili L, Adeli K. Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays. Clinical Chemistry and Laboratory Medicine (CCLM). 2021 Jan 21;1(ahead-of-print).
  117. Tacker DH, Bashleben C, Long TC, Theel ES, Knight V, Kadkhoda K, Rhoads DD, Linden MA, Fink SL. Inter-laboratory Agreement of Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Serologic Assays in the Expedited College of American Pathologists Proficiency Testing Program. Arch Pathol Lab Med. 2021 Jan 18. doi: 10.5858/arpa.2020-0811-SA. Epub ahead of print. PMID: 33461214.
  118. Verkerke H, Horwath M, Saeedi B, Boyer D, Allen JW, Owens J, Arthur CM, Nakahara H, Rha J, Patel K, Wu SC, Paul A, Yasin N, Wang J, Shin S, Brown D, Normile K, Cole L, Meyers M, Lin H, Woods E, Isaac J, Broder K, Wade J, Kauffman RC, Patel R, Josephson CD, Reynolds S, Sherman M, Wrammert J, Alter D, Guarner J, Roback JD, Neish A, Stowell SR. Comparison of Antibody Class Specific SARS-CoV-2 Serology for the Diagnosis of Acute COVID-19. J Clin Microbiol. 2021 Jan 19:JCM.02026-20. doi: 10.1128/JCM.02026-20. Epub ahead of print. PMID: 33468605.
  119. Mullins KE, Merrill V, Ward M, King B, Rock P, Caswell M, Ahlman M, Harris AD, Christenson R. Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers. Clin Biochem. 2021 Jan 17:S0009-9120(21)00005-9. doi: 10.1016/j.clinbiochem.2021.01.004. Epub ahead of print. PMID: 33472036; PMCID: PMC7813506.
  120. Lippi G, et al. Raccomandazioni ad interim di SIBioC per l'analisi sierologica dell'infezione da SARS-CoV-2. Biochiica Clinica. DOI: 19186/BC_2021.002
  121. Brown SD, Ottaway KA, Weaving G, Shipman KE. Response to: towards the rational utilization of SARS-CoV-2 serological tests in clinical practice. Clin Chem Lab Med. 2021 Jan 13. doi: 10.1515/cclm-2020-1762. Epub ahead of print. PMID: 33554513.
  122. Irsara C, Egger AE, Prokop W, Nairz M, Loacker L, Sahanic S, Pizzini A, Sonnweber T, Mayer W, Schennach H, Loeffler-Ragg J, Bellmann-Weiler R, Tancevski I, Weiss G, Anliker M, Griesmacher A, Hoermann G. Evaluation of four commercial, fully automated SARS-CoV-2 antibody tests suggests a revision of the Siemens SARS-CoV-2 IgG assay. Clin Chem Lab Med. 2021 Jan 14. doi: 10.1515/cclm-2020-1758. Epub ahead of print. PMID: 33554557.
  123. Morshed M, Sekirov I, McLennan M, Levett PN, Chahil N, Mak A, Carruthers E, Pidduck T, Kustra J, Laley J, Lee MK, Chu K, Burgess F, Vijh R, Willis L, Wada R, Blancaflor R, Boraston S, Hayden A, Krajden M. Comparative Analysis of Capillary vs Venous Blood for Serologic Detection of SARS-CoV-2 Antibodies by RPOC Lateral Flow Tests. Open Forum Infect Dis. 2021 Jan 28;8(3):ofab043. doi: 10.1093/ofid/ofab043. PMID: 33723509; PMCID: PMC7928643.
  124. Bal A, Pozzetto B, Trabaud MA, Escuret V, Rabilloud M, Langlois-Jacques C, Paul A, Guibert N, D'Aubarede-Frieh C, Massardier-Pilonchery A, Fabien N, Goncalves D, Boibieux A, Morfin-Sherpa F, Pitiot V, Gueyffier F, Lina B, Fassier JB, Trouillet-Assant S; COVID SER STUDY GROUP. Evaluation of high-throughput SARS-CoV-2 serological assays in a longitudinal cohort of patients with mild COVID-19: clinical sensitivity, specificity and association with virus neutralization test. Clin Chem. 2021 Jan 5:hvaa336. doi: 10.1093/clinchem/hvaa336


Breath Testing:



Additional Resources Related to Testing:

Website developed by Insoft